Moreover, p53 FOXP1 has also been described as a miR-34a target, where miR-34a downregulation results in higher levels of FOXP1 and BCL6, which in turn supports DLBCL proliferation [53,54,55]. The gene discussed is FOXP1; the disease is diffuse large B-cell lymphoma.